De novo genic mutations among a Chinese autism spectrum disorder cohort

Nat Commun. 2016 Nov 8;7:13316. doi: 10.1038/ncomms13316.

Abstract

Recurrent de novo (DN) and likely gene-disruptive (LGD) mutations contribute significantly to autism spectrum disorders (ASDs) but have been primarily investigated in European cohorts. Here, we sequence 189 risk genes in 1,543 Chinese ASD probands (1,045 from trios). We report an 11-fold increase in the odds of DN LGD mutations compared with expectation under an exome-wide neutral model of mutation. In aggregate, ∼4% of ASD patients carry a DN mutation in one of just 29 autism risk genes. The most prevalent gene for recurrent DN mutations is SCN2A (1.1% of patients) followed by CHD8, DSCAM, MECP2, POGZ, WDFY3 and ASH1L. We identify novel DN LGD recurrences (GIGYF2, MYT1L, CUL3, DOCK8 and ZNF292) and DN mutations in previous ASD candidates (ARHGAP32, NCOR1, PHIP, STXBP1, CDKL5 and SHANK1). Phenotypic follow-up confirms potential subtypes and highlights how large global cohorts might be leveraged to prove the pathogenic significance of individually rare mutations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian Continental Ancestry Group / genetics
  • Autism Spectrum Disorder / genetics*
  • Cohort Studies
  • DNA Mutational Analysis
  • Exome / genetics
  • Genetic Predisposition to Disease
  • Geography
  • Humans
  • Inheritance Patterns / genetics
  • Mutation / genetics*
  • Phenotype
  • Polymorphism, Single Nucleotide / genetics
  • Risk Factors